Last reviewed · How we verify

NCT05742152

Reliability and Validity of Outcome Measures for Pain in Multiple Sclerosis

Completed Last updated 12 July 2024
What this trial tests

trial in Pain in 60 participants. Completed in 1 May 2024.

Timeline
1 April 2023
Primary endpoint
23 April 2024
1 May 2024

Quick facts

Lead sponsorHasselt University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 April 2023
Primary completion23 April 2024
Estimated completion1 May 2024
Sites4 locations across Belgium, Chile

Conditions studied

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to provide values of test-retest reliability and insights from concurrent validity of outcome measures for pain in multiple sclerosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessing pain in multiple sclerosis: Test-retest reliability of patient-reported outcome measures and accuracy of screening tools.
    Yilmazer C, D'haeseleer M, Soler B, Van Wijmeersch B, et al · · 2025 · cited 1× · PMID 39819131 · DOI 10.1177/13524585241310139

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05742152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing